Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment

Lancet Neurology

Volumn 2, Issue 1, 2003, Pages 15-21

  DeCarli, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR;

AGING; ALZHEIMER DISEASE; CELL LOSS; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DISEASE CLASSIFICATION; DISEASE COURSE; EARLY DIAGNOSIS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NERVE CELL; NONHUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; REDUCTION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SENILE PLAQUE; WHITE MATTER; WORKING MEMORY; AGED; CEREBRAL ARTERY DISEASE; NOMENCLATURE; TREATMENT OUTCOME;

AGED; COGNITION DISORDERS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MEMORY DISORDERS; PROGNOSIS; TERMINOLOGY; TREATMENT OUTCOME;

EID: 0042512345     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00262-X     Document Type: Review

References (86)

1. Hebert L.E., Beckett L.A., Scherr P.A., Evans D.A. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord. 15:2001;169-173.
2. Cutler S.J., Grams A.E. Correlates of self-reported everyday memory problems. J Gerontol. 43:1988;S82-90.
3. La Rue A. Aging and neuropsychological assessment. 1992;Plenum Press, New York.
4. Robertson D., Rockwood K., Stolee P. The prevalence of cognitive impairment in an elderly Canadian population. Acta Psychiatr Scand. 80:1989;303-309.
5. Graham J.E., Rockwood K., Beattie B.L., et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 349:1997;1793-1796.
6. Wilson R.S., Beckett L.A., Bennett D.A., Albert M.S., Evans D.A. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol. 56:1999;1274-1279.
7. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol. 45:1999;358-368.
8. Morris J.C., Storandt M., Miller J.P., et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 58:2001;397-405.
9. Morris J.C. Is Alzheimer's disease inevitable with age? Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer's disease. JClinInvest. 104:1999;1171-1173.
10. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 56:1999;303-308.
11. Petersen R.C., Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol. 58:2001;1985-1992.
12. Bozoki A., Giordani B., Heidebrink J.L., Berent S., Foster N.L. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol. 58:2001;411-416.
13. Ritchie K., Artero S., Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology. 56:2001;37-42.
14. Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 88:1998;1337-1342.
15. Ritchie K., Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 355:2000;225-228.
16. Collie A., Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev. 24:2000;365-374.
17. DeCarli C., Miller B.L., Swan G.E., Reed T., Wolf P.A., Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 58:2001;643-647.
18. Kral V.A. Senescent forgetfulness: benign and malignant. Can Med Assoc J. 86:1962;257-260.
19. Crook T., Bartus R.T., Ferris S.H., et al. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol. 2:1986;261-276.
20. Blackford R.C., La Rue A. Criteria for diagnosing age associated memory impairment: proposed improvements in the field. Dev Neuropsychol. 5:1989;295-306.
21. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 6:1994;63-68.
22. American Psychiatric Association. Diagnostic and statistical manual, 4th edn. Washington: American Psychiatric Association, 1994.
23. WHO. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: WHO, 1993.
24. Goldman W.P., Morris J.C. Evidence that age-associated memory impairment is not a normal variant of aging. Alzheimer Dis Assoc Disord. 15:2001;72-79.
25. Jonker C., Geerlings M.I., Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry. 15:2000;983-991.
26. Shah S., Tangalos E.G., Petersen R.C. Mild cognitive impairment: when is it a precursor to Alzheimer's disease? Geriatrics. 55:2000;65-68.
27. Petersen R.C. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. 15:2000;93-101.
28. Petersen R.C. Aging, mild cognitive impairment, and Alzheimer's disease. Neurol Clin. 18:2000;789-806.
29. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology. 56:2001;1133-1142.
30. Christensen H., Henderson A.S., Jorm A.F., Mackinnon A.J., Scott R., Korten A.E. ICD-10 mild cognitive disorder: epidemiological evidence on its validity. Psychol Med. 25:1995;105-120.
31. Rockwood K., Wentzel C., Hachinski V., et al. Prevalence and outcomes of vascular cognitive impairment. Neurology. 54:2000;447-451.
32. Reed B.R., Eberling J.L., Mungas D., Weiner M.W., Jagust W.J. Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann Neurol. 48:2000;275-284.
33. Swan G.E., DeCarli C., Miller B.L., Reed T., Wolf P.A., Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology. 54:2000;2108-2114.
34. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn. Washington, DC: American Psychiatric Association, 1987.
35. Graham J.E., Rockwood K., Beattie B.L., McDowell I., Eastwood R., Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology. 15:1996;246-256.
36. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Kokmen E., Tangelos E.G. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 9:(suppl 1):1997;65-69.
37. Berg L., Hughes C.P., Coben L.A., Danziger W.L., Martin R.L., Knesevich J. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry. 45:1982;962-968.
38. Morris J.C., McKeel D.W. Jr, Fulling K., Torack R.M., Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 24:1988;17-22.
39. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
40. Palmer K., Wang H.X., Backman L., Winblad B., Fratiglioni L. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatry. 159:2002;436-442.
41. Frisoni G.B., Fratiglioni L., Fastbom J., Guo Z., Viitanen M., Winblad B. Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95. J Gerontol A Biol Sci Med Sci. 55:2000;M322-328.
42. Frisoni G.B., Fratiglioni L., Fastbom J., Viitanen M., Winblad B. Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors. Am J Epidemiol. 150:1999;1031-1044.
43. Riley K.P., Snowdon D.A., Markesbery W.R. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol. 51:2002;567-577.
44. O'Connor D.W. Memory complaints and impairment in normal, depressed and demented elderly persons identified in a community survey. Arch Gen Psychiatry. 47:1990;224-227.
45. Lautenschlager N.T., Riemenschneider M., Drzezga A., Kurz A.F. Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord. 12:2001;379-386.
46. Morris J.C., Price A.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 17:2001;101-118.
47. Bouras C., Hof P.R., Morrison J.H. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett. 153:1993;131-135.
48. D'Agostino R.B., Belanger A.J., Kannel W.B. Probability of stroke: a risk profile from the Framingham Study. Stroke. 22:1991;312-318.
49. Wu C.C., Mungas D., Petkov C.I., et al. Structural brain changes and cognitive impairment in a community sample: the SALSA Study. Neurology. 59:2002;383-391.
50. Slooter A.J., van Duijn C.M., Bots M.L., et al. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. J Neural Transm Suppl. 53:1998;17-29.
51. Launer L.J., Ross P.W., Petrovitch H., et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 21:2000;49-55.
52. Skoog I., Lernfelt B., Landahl S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 347:1996;1141-1145.
53. Kivipelto M., Helkala E.L., Hanninen T., et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 56:2001;1683-1689.
54. Kivipelto M., Helkala E.L., Laakso M.P., et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 322:2001;1447-1451.
55. Kivipelto M., Laakso M.P., Tuomilhelto J., et al. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention. CNS Drugs. 16:2002;435-444.
56. Rockwood K., Howard K., MacKnight C., Darvesh S., et al. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology. 18:1999;248-254.
57. Fein G., Di Sclafani V., Tanabe J., et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 55:2000;1626-1635.
58. de Leeuw F.E., de Groot J.C., Bots M.L., et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol. 247:2000;291-296.
59. Manolio T.A., Kronmal R.A., Gurke G.L., et al. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke. 25:1994;318-327.
60. Longstreth W.T. Jr, Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke. 27:1996;1274-1282.
61. Bartres-Faz D., Junque C., Lopez-Alomar A., et al. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. J Am Geriatr Soc. 49:2001;985-990.
62. Tierney M.C. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 57:2001;163-164.
63. Tierney M.C., Szalai J.P., Dunn E., Geslani D., McDowell I. Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment: value of the Mini-Mental State Examination. Arch Fam Med. 9:2000;527-532.
64. Tierney M.C., Szalai J.P., Snow W.G., et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology. 46:1996;149-154.
65. Wentzel C., Rockwood K., MacKnight C., et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 57:2001;714-716.
66. Bennett D.A., Wilson R.S., Schneider J.A., et al. Natural history of mild cognitive impairment in older persons. Neurology. 59:2002;198-205.
67. Marquis S., Moore M.M., Howieson D.B., et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol. 59:2002;601-606.
68. Visser P.J., Sheltens P., Verhey F.E.R., et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 246:1999;477-485.
69. Jack C.R. Jr, Petersen R.C., Xu Y.C., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1999;1397-1403.
70. Petersen R.C., Waring S.C., Smith G.E., Tangalos E.G., Thibodeau S.N. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann N Y Acad Sci. 802:1996;58-69.
71. Jack C.R. Jr, Petersen R.C., Xu Y.C., et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 49:1997;786-794.
72. Kaye J.A., Swihart T., Howieson D., et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 48:1997;1297-1304.
73. Fox N.C., Warrington E.K., Freeborough P.A., et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain. 119:1996;2001-2007.
74. Fox N.C., Warrington E.K., Stevens J.M., et al. Atrophy of the hippocampal formation in early familial Alzheimer's disease: a longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation. Ann N Y Acad Sci. 777:1996;226-232.
75. Grundman M., Sencakova D., Jack C.R. Jr, et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci. 19:2002;23-27.
76. de Leon M., Golomb J., George A.E., et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol. 14:1993;897-906.
77. Tabert M.H., Albert S.M., Burokhova-Milov L., et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 58:2002;758-764.
78. Albert S.M., Tabert M.H., Dienstag A., Pelton G., Devanand D. The impact of mild cognitive impairment on functional abilities in the elderly. Curr Psychiatry Rep. 4:2002;64-68.
79. Wolf H., Ecke G.M., Bettin S., Dietrich J., Gertz H.J. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 15:2000;803-812.
80. Mungas D., Jagust W.J., Reed B.R., et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology. 57:2001;2229-2235.
81. Mungas D., Reed B.R., Ellis W.G., Jagust W.J. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol. 58:2001;1243-1247.
82. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 277:1997;813-817.
83. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 352:1998;1347-1351.
84. Hansson L. Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial. J Hypertens. 17:1999;307-308.
85. Birkenhager W.H., Forette F., Seux M.L., Wang J.G., Staessen J.A. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med. 161:2001;152-156.
86. Barker W.H., Mullooly J.P., Linton K.L. Trends in hypertension prevalence, treatment, and control: in a well-defined older population. Hypertension. 31:1998;552-559.